BLISS GVS Pharma informs about outcome of board meeting

30 Dec 2022 Evaluate
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, BLISS GVS Pharma has informed that the Board of Directors of the Company at their meeting held today i.e., Friday, December 30, 2022 had considered and approved the Appointment of Deepak Sawant as Chief Financial Officer of the Company with effective from today i.e., December 30, 2022. (Disclosure pursuant to SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is enclosed herewith as 'Annexure-I'). 

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

129.00 8.25 (6.83%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.